Vestal Point Capital

Vestal Point Capital is an investment firm specializing in life sciences, managing a diversified portfolio across biotechnology, pharmaceuticals, medical devices, and diagnostics. The firm utilizes comprehensive research, extensive industry experience, and rigorous risk management. Their approach focuses on disciplined execution to capitalize on market opportunities, generating idiosyncratic excess returns.

Ryan Wilder founded Vestal Point Capital in 2023, serving as its Managing Partner and Chief Investment Officer. His founding insight stemmed from proprietary scientific and financial analysis revealing investment opportunities often overlooked by the broader market. Wilder’s extensive prior healthcare investment experience informs the firm's strategic focus.

Vestal Point Capital serves investors seeking specialized exposure to the dynamic life sciences market. The firm’s vision centers on leveraging healthcare innovation, ensuring capital protection and striving for positive returns across varied market environments. They aim to deliver favorable long-term outcomes for partners through diligent investment application.